(Update 9:45 a.m.): Updated with conference call information and stock price. NEW YORK (TheStreet) -- Celgene fell 2.01% to $87.33 in early morning trading on Thursday after the biotechnology company reported mixed second-quarter results. Celgene reported a year-over-year increase in net profit to $597.8 million, or 72 cents a share, from $478.1 million, or 56 cents a share.